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Diplococcus pneumoniae elaborates a heat labile
substance capable of lysing rabbit erythrocytes in vitro
and in vivo (Shumway and Pollock, 1965) . It has
been suggested (Shumway and Pollock, 1965) that
this substance may be responsible for the hemolytic
anemia which occurs in rabbits with pneumococcal
septicemia (Shumway, 1958) but proof for this
hypothesis is still lacking.
The purposes of this report are to describe a method
of preparing a potent crude pneumococcal hemolysin,
to define some of its characteristics, and to describe
the effects of its administration to rabbits.

Methods
Preparation of Crude Hemolysin

The microorganism utilized in these studies was a
strain of Diplococcus pneumoniae, type 1, kindly supplied by Herbert Morgan. As the microorganism
grows in glucose-enriched brain-heart infusion broth,
it elaborates a hemolysin which can be precipitated
from the supernatant broth by ammonium sulfate.
Because early investigations suggested that the hemolysin was an endotoxin (Cole, 1914), attempts were
made to extract the hemolytic substance from bacterial
cells rather than from the supernatant broth. Preliminary studies disclosed that hemolytically active
extracts could be obtained when the bacteria were
disrupted enzymatically with lysozyme, osmotically
with distilled water, or mechanically with glass beads
or high frequency sound. Sonic disintegration proved
to be the simplest and most efficient method of cell
disruption.
A potent crude hemolysin was prepared in the following manner: Three liters of brain-heart infusion
broth (Difeo) containing glucose in a final concentration of 500 mg/ 100 ml was inoculated with 300 ml of
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a 6 to 8 hr broth culture of Diplococcus pneumoniae, type 1. The broth was maintained at 37 C
in an atmosphere of nitrogen and was mixed continuously with a magnetic stirrer. Aliquots were withdrawn at 30 to 60 min intervals to measure turbidity
at 650 m,u., pH and glucose concentration. The pH,
which decreased rapidly during the logarithmic phase
of bacterial growth, was maintained between 7.0 and
7.5 by the gradual addition of sterile 5N sodium carbonate. Glucose concentration was maintained between 400 and 600 mg/ 100 ml by the addition of
sterile 50% glucose solution. When the optical density
of the culture reached its maximum ( 6-8 hr) the
broth was placed at 4 C under nitrogen for 18 hr.
It was then centrifuged at 18,000 G in a continuous
flow system; this centrifugation and all subsequent
manipulations were carried out at 5 C.
The sedimented bacteria were suspended in approximately two volumes of cold distilled water and subjected to high frequency sound (Branson Model S-75
Sonifier at full power) for a total of 10 min. The
sonication was carried out at 1 min intervals so that
the temperature of the bacterial suspension did not rise
above 10 C. The material was then centrifuged at
18,000 G for 30 min, and the supernate, which contained the hemolysin, was removed and frozen at
- 20 C until further steps could be carried out.
Preliminary studies using step-wise fractionation
disclosed that the hemolysin was precipitated from the
bacterial liquor between 20 and 60% saturation with
ammonium sulfate. All subsequent preparations of the
hemolysin were made with the precipitate formed
between these two concentrations of this salt. The
precipitate was dissolved in distilled water and dialyzed
against cold distilled water until the dialysis bath no
longer reacted with Nessler's reagent. The dialyzed
material was then divided into aliquots, freeze-dried,
vacuum sealed and stored at - 20 C until further use.
The hemolytic activity of this extract varied from
batch to batch; ordinarily it required 0.006 to .01 ml
of the material (equivalent to 87-145 µ.g of protein)
to completely lyse 1 ml of human or rabbit erythrocytes. In its freeze-dried state the hemolysin maintained
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its potency for at least 5 years. When it was stored in
solution at room temperature for 8 days, there was a
four-fold reduction in its hemolytic activity; when
stored in solution at -20 C for 12 months, there was
a 16-fold reduction in its activity. In the latter instance,
part of its activity could be restored by the addition of
0.4 M cysteine.

Hemolysin Assay
Maximal lysis of either human or rabbit erythrocytes
by the hemolysin occurred within 60 min at 37 C.
Two methods of quantitation were used for the studies
to be reported here. The first involved the addition
of 0.5 ml of a known dilution of the hemolysin to 1 ml
of a 50% suspension of thrice washed rabbit or human
erythrocytes in isotonic sodium chloride solution; this
mixture was incubated for 60 min at 37 C, centrifuged
at 3000 G for 5· min, and the amount of hemoglobin
released into the supernatant solution was measured
spectrophotometrically. Results were expressed as percentage of red cells lysed. This method was satisfactory for much of the early work where gross
differences of hemolysis were evident, but when differences were more subtle, a more sensitive method of
assay was needed.
For this latter purpose, serial dilutions of the
hemolysin were made in 0.85% sodium chloride solution. One ml of a 3 % suspension of thrice washed
human or rabbit erythrocytes in isotonic saline was
added to an equal volume of each dilution of hemolysin. The tubes containing these mixtures were mixed
thoroughly and incubated for 60 min at 37 C. After
incubation, the contents of the tubes were mixed
again, centrifuged at 2000 G for 2 min, and the
degree of hemolysis graded on a scale of from 0 to
4+ (complete hemolysis). Results using this method
were reproducible within one tube dilution.

Hemolysin Inhibition Titer
Two-fold serial dilutions of the serum under investigation were made using 0.85% sodium chloride as diluent. Five-tenths milliliter of each serum dilution was
mixed with 0.5 ml of diluted hemolysin; the concentration of hemolysin used was one tube dilution less
than that dilution which produced complete lysis of
the standard red cell suspension. After the mixtures of
serum and hemolysin had been incubated at 37 C for
15 min, 1 ml of a 3% suspension of washed rabbit
erythrocytes was added to each tube. The contents of
the tubes were thoroughly mixed, incubated at 37 C
for 60 min, centrifuged at 3000 G for 2 min, and
examined for hemolysis. The highest dilution of
serum which completely inhibited hemolysis under
these conditions was termed the "hemolysin inhibition
titer." Results were reproducible from day to day
within two tube dilutions, but whenever two or more
sera were compared they were analyzed simultaneously.
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TABLE I

Effect of Trypsin on Pneumococcal Hemolysin
Hemolysin Dilution Trypsin-Percent Percent Hemolysis
1 : 200
1: 200
1: 200

0
.0009

0
0

.0009

94
85
2

.009

1
1

.009

Crystalline trypsin was dissolved in M/ 15 phosphate
buffer pH 7.3 and mixed with the crude bacterial
extract (hemolysin) so that final concentrations were
as above. Control tubes contained isotonic saline solution. After 30 min at 37 C, 0.5 ml of each mixture
was added to 1 ml of 50% suspension of washed
rabbit erythrocytes, tubes mixed arid incubated at 37 C
for 60 min and centrifuged. Percentage of cells lysed
was measured spectrophotometrically.

TABLE II

Effect of Cholesterol on Pneumococcal Hemolysin
Cholesterol
Hemolysin Dilution mg/ 100 ml
Percent hemolysis
1: 200
1: 200
1 : 200

0
0

0
90
9
90
9

93

<
<
<
<

Cholesterol suspended in isotonic sodium chloride
solution was mixed with bacterial extract (hemolysin)
to give final concentrations noted above. Control tubes
contained isotonic saline solution. After 30 min at
37 C, 0.5 ml of each mixture was added to 1 ml of
a 50% suspension of washed rabbit erythrocytes in
isotonic sodium chloride. Tubes were mixed thoroughly, incubated 60 min at 37 C and centrifuged.
Percentage of cells lysed was measured spectrophotometrically.
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As an additional control, at the time of each assay
a "standard serum" of known inhibitory effect was also
analyzed; these results were always within one tube
dilution.
The animals used for in vivo studies were mature
male albino rabbits. Blood was obtained from marginal ear veins and measurements of packed red cell
volume and erythrocyte osmotic fragility were made
by standard methods (Shumway and Pollock, 1965).
The degree of hemoglobinemia was estimated qualitatively by inspection of supernatant plasma.

I

Results
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The hemolysin present in this bacterial extract exhibited characteristics similar to those described by
others working with "pneumococcal hemolysin,"
"pneumotoxin," or "pneumococcus hemotoxin"
(Cohen, Halbert and Perkins, 1942; Cole, 1914;
Cowan, 1934; Fleming and Neill, 1927; Halbert,
Cohen and Perkins, 1946; Neill, 1926; Weiss, 1918).
Hemolytic activity was abolished by heating to 56 C
for 10 min and by exposure of the hemolysin to
trypsin (Table I) or cholesterol (Table II) .
Sodium cyanide 0.02m and disodium-EDTA 0.003m
exhibited no inhibitory effects. Normal human sera
and normal rabbits' sera exhibited slight inhibitory
effect, the former more than the latter.
The effect of temperature upon the interaction of
hemolysin and erythrocytes was noteworthy. When
hemolysin and either human or rabbit red blood cells
were incubated together for 60 min at temperatures
between 4 C and 37 C, the 'degree of hemolysis was
greater at the higher temperatures (Fig 1), At 4 C
hemolysis was virtually absent. When erythrocytes
which had been exposed to hemolysin for 60 min at
4 C were washed three times with 10 volumes of
cold isotonic saline solution, resuspended to their
original volume and incubated at 37 C for 60 min,
lysis occurred. The supernatant material from the
original mixture of hemolysin and erythrocytes failed
to lyse fresh erythrocytes when exposed to them at 37
C for 60 min.
Earlier studies had shown that the intravenous administration of supernatant broth from a culture of
Diplococcus pneumoniae to rabbits resulted in intravascular hemolysis (Shumway and Pollock, 1965). As
will be demonstrated, this same phenomenon was
observed after injection of crude bacterial extract. Because the characteristics of the hemolysin suggested
that it was a protein or contained protein as an
integral part of its structure, it was likely to be
antigenic. The results of the following experiments
are compatible with this hypothesis.
Normal mature male albino rabbits were selected at
random. Blood samples were obtained for baseline
measurements of red blood cell morphology, packed
red cell volume and erythrocyte osmotic fragility; an
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Fig I-Effect of temperature upon the lysis of human
erythrocytes by pneumococcal hemolysin.
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aliquot of serum was frozen for subsequent determination of the "hemolysin inhibition titer." A standard
amount of the crude bacterial hemolysin (0.2 ml/kg)
diluted in isotonic sodium chloride solution was given
intravenously to each rabbit, and 2 hr later a second blood sample was obtained to reassess the
above mentioned parameters.
The results are summarized in Table III. Twelve of
22 rabbits exhibited unequivocal evidence of intravascular hemolysis as manifested by a 6% or greater
decrease in packed red cell volume, an increase of
erythrocyte osmotic fragility and hemoglobinemia. The
animals' erythrocytes were found to be spherocytic or
to have a crenated or spiculated appearance (Fig 2).
Abnormalities of at least one or two of these parameters were evident in nine other animals. The one
rabbit which failed to exhibit any evidence of hemoly-

sis was subsequently found to have a high "hemolysin
inhibition titer" (1/ 5120) without any known prior
exposure to the hemolysin.
Nine of the rabbits which had been challenged by
the intravenous injection of the hemolysin were given
"booster doses" of the material (one-fourth original
amount) intramuscularly, 9, 12, and 14 days after
the original challenge. On the 21st day the sera of
seven of the nine animals had an increased ability to
inhibit the hemolysin in vitro; the "hemolysin inhibition titers" rose from 1/80 or less to values from
1/640 to 1/ 5120. When these immunized rabbits were
challenged a second time by the intravenous injection
of the standard amount of hemolysin, none exhibited
any evidence of intra vascular hemolysis (Fig 3;
Table III).

Fig 2-Photomicrographs of rabbit's blood smear (Wright Stain) . (A) Normal rabbit. (B) Same animal 2 hr after intravenous administration of pneumococcal hemolysin. Note presence of spherocytes and "spiculated" erythrocytes.
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TABLE III
Effects of Administration of Pneumococcal Hemolysin to Normal and Immunized Rabbits
FIRST INJECTION OF PNEUMOCOCCAL HEMOLYSIN
Hemolysin Change in*
Rabbit Inhibition
PCV
No.
Titer
%
127
128
130
133
141
142
147
151
152
183
184
185
. 186
129
131
132
134
144
145
146
153
157

SECOND INJECTION OF PNEUMOCOCCAL
HEMOLYSIN

Increase of**
Erythrocyte
Hemolysin Change in
PCV
Inhibition
Osmotic
Fragility
Hemoglobinemia
Titer
%

1/ 10
1/ 10
1/ 20
< 1/ 10
1/ 80
1/ 160
1/ 5120
<1/10
< 1/ 10
1/ 40
<1 / 10
1/ 10
< 1/ 10

-13
-17
-5
-1
-3
-3
-4
-23
-25
-2
0
- 11
- 14

+
+
0
0
+
0
0
+
+
0
+
+
+

+
+
+
+
+
+
0
+
+
+
+
+
+

1/ 10
1/ 20
<1 / 10
< 1/ 10
1/ 80
<1 / 10
< l/10
1/80
1/ 40

-4
-10
-18
-13
- 11
-5
- 3
-7
-7

+
+
+
+
+
0
0
+
+

+
+
+
+
+
+
+
+
+

1/ 640
1 / 1280
1/1280
1 / 1280
1/80
>1 / 5120
1/ 2560
1/ 80
1/ 640

0
+2
-3
- 3
+6
- 1
- 3
-5
+2

Increase of
Erythrocyte
Osmotic
Fragility
Hemoglobinemia

0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

* Packed red cell volume (hematocrit)

* + Denotes an increase beyond two standard deviations of normal mean

A surprising phenomenon was noted in five of six
rabbits that were studied in more detail. On the first
and second day after the first intravenous injection of
the bacterial product, the animals' "hemolysin inhibition titer" rose transiently, but by the fifth day the
results returned to the previous low values. Coincident
with the transient rise 'in "inhibition titer" these sera
appeared opalescent as if hyperlipe mic.
Discussion
Libman ( 1905) is credited with first describing the
lysis of erythrocytes by Diplococcus pneumoniae. Nine
years later Cole ( 1914) prepared an extract of
pneumococcal cell bodies which lysed human, rabbit,
sheep, and guinae pig erythrocytes. He noted that
the hemolysin was inactivated by trypsin, cholesterol,
heat (55 C for 30 min), and by the sera of animals
which had been immunized with the material.
From 1914 to 1946 many investigators (Cohen,

Halbert and Perkins, 1942; Cole, 1914; Cowan, 1934;
Fleming and Neill, 1927; Halbert, Cohen and Perkins,
1946; Neill, 1926; Weiss, 1918) working with crude
bacterial cell extracts studied the properties of the
hemolysin and arrived at the following conclusions :
The substance responsible for the hemolytic property
of the pneumococcus is present within the bacterial
cells, and under some conditions it is elaborated
into the culture medium. The hemolysin is heat
labile (56 C for 3 min) and is inactivated by trypsin,
cholesterol, red blood cell stroma, and oxidizing
agents. Oxidation by air and mild chemical oxidants
is partially reversed by reducing agents. H albert,
Cohen and Perkins (1946) produced evidence which
suggested that the hemolysin also exhibited dermotoxic
and lethal toxicity. Recently, Kreger and Bernheimer
( 1969) found that the hemolysin behaved as an
acidic protein with an isoelectric pH of 4.9 apd a
molecular weight of approximately 63,000. In some
respects it is thought to resemble streptolysin O; Todd
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( 1934) demonstrated that the sera from animals
:immunized with streptolysin 0 partially inhibited
'pneumococcal hemolysin. However, Tunevall (1953)
noted that in human infections there was no significant
;n eutralization of "pneumolysin" by antistreptolysin
immune sera or of streptolysin 0 by "antipneumolysin"
sera.
A great deal of effort was expended to determine
the role, if any, which the hemolysin played in the
pathogenesis of pneumococcal infections. All investigators who administered the material to experimental
animals commented upon the absence of demonstrable
hemolysis in vivo. Although it has not been shown that
this substance plays a significant part in the disease
process, this possibility has not been excluded.
With the advent of chemotherapeutic agents and
antibiotics, interest in Diplococcus pneumoniae waned.
In 1958 it was noted that pneumococcal septicemia in
rabbits was associated with a spherocytic hemolytic
anemia. (Shumway, 1958) Later it was found that
,t he intravenous administration to rabbits of supernatant broth from cultures of Diplococcus pneumoniae,
type l, resulted in spherocytosis, increased erythrocyte
osmotic fragility and intravascular hemolysis (Shumway and Pollock, 1965). This observation suggested
that pneumococcal septicemia of rabbits might offer a
model in which to test the hypothesis that this bac-

terial hemolysin plays a role in the .pathogenesis of
pneumococcal infections. The studies reported here
represent a step toward this goal.
The results of these studies demonstrate that a
crude extract of Diplococcus pneumoniae, type 1 cells,
damages and lyses human and rabbit erythrocytes in
vitro and rabbit erythrocytes in vivo. The characteristics of our material suggest that it contains the same
products which other workers have described as
"pneumolysin," "pneumococcal hemolysin," "pneumococcal hemotoxin" and "pneumotoxin." The observation that the sera of rabbits which have received multiple injections of the material are able to neutralize
the hemolysin in vitro, suggests that the material is
antigenic. This suggestion is strengthened by the
demonstration that an immunized rabbit does not
experience hemolysis when challenged by an intravenous injection of the active hemolysin.
Although the term "hemolysin" has been used
to describe this bacterial product, the term should not
be taken literally. Halbert, Cohen and Perkins ( 1946)
presented evidence which suggested that the material
was lethal to mice and dermotoxic to guinea pigs.
Robert Post working with our crude material has
demonstrated that it damages and destroys human
AV 3 cells in tissue culture, and that this cytotoxic
effect is abolished by heating the bacterial extract for
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Fig 3-Effect of administration of pneumococcal hemolysin to a normal rabbit (A); and to same immunized animal
(B) 21 days later. Shaded area represents the normal range (± 2 SD) of erythrocyte osmotic fragility. Measurements
made 2 hr after injection of the hemolysin.
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10 min at 56 Corby prior mixing of the extract with
serum of an immunized rabbit. Thus, the "hemolysin"
may have an affinity for and effect upon many cells
including the erythrocyte.
The major weakness of this study and the work of
others is the heterogeneity of the bacterial product. It
is truly a crude extract; analytical disc gel electrophoresis of the material discloses the presence of many
bands of protein. Before the question of its significance in the pathogenesis of pneumococcal infections
can be answered and before its mechanism of action
can be determined, a purified preparation must be
obtained.
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